Source: PR Newswire

Press Release: Cellphire : Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management

With the closing of a new funding round, Cellphire has entered its next exciting phase and is poised for rapid growth. Stephen H. Willard, a major shareholder, has decided to step away from his role as CEO and the Board in order to bring in a new CEO to take the company through its new phase of expansion and growth. The Board has identified the company's new CEO who will start with the company in the near future. In the interim, Rafael Jorda, who has been with the company since 2015, will be the acting CEO and manage the company with the assistance of the Executive Management Team.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael Gaffney's photo - President & CEO of Cellphire

President & CEO

Michael Gaffney

CEO Approval Rating

90/100

Read more